Sectors
SRZN
Surrozen, Inc.
16.55
1 x 16.45
1 x 17.51
bid
ask
-
0.39
2.30%
1 @ 04:00 PM
16.55 +0.00 (0.00%)
| Ytd | -26.77% | |
| 1y | 38.15% |
16.43
day range
17.68
11.39
52 week range
35.00
| Open | 16.97 | Prev Close | 16.94 | Low | 16.43 | High | 17.68 | Mkt Cap | 194.52M |
| Vol | 190.17K | Avg Vol | 218.80K | EPS | -40.06 | P/E | N/A | Forward P/E | -2.75 |
| Beta | 0.56 | Short Ratio | 0.97 | Inst. Own | 77.18% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-09 | 50-d Avg | 21.81 | 200-d Avg | 24.25 | 1yr Est | 33.00 |
SRZN News
seekingalpha.com
Surrozen, Inc. (SRZN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Surrozen, Inc. (SRZN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
benzinga.com
Surrozen Submits IND Application To FDA Seeking To Evaluate SZN-8141, Bifunctional Wnt Agonist And V
Surrozen, Inc. (Surrozen or the Company) (NASDAQ:SRZN), a biotechnology company pioneering targeted